<scp>TMEM252</scp> inhibits epithelial–mesenchymal transition and progression in papillary thyroid carcinoma by regulating Notch1 expression
Our study elucidates that TMEM252 suppresses PTC progression by modulating the Notch pathway. These findings underscore TMEM252 is a potential therapeutic target in managing PTC.
Authors
- Y Zhang (ORCID: https://orcid.org/0009-0003-8454-2252)
- Jichun Yu (ORCID: https://orcid.org/0009-0008-9096-1716)
- Shuyong Zhang (ORCID: https://orcid.org/0000-0002-9739-2682)
- Chenxi Zhang (ORCID: https://orcid.org/0000-0001-8929-7506)
- Rong Xie (ORCID: https://orcid.org/0000-0003-1889-915X)
- Guoxue Fu
- Liuhuan Wang
Institutions
- Nanchang University (CN)
- Second Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Head & Neck
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1002/hed.27922
- Citations
- 3
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.07